Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s diseaseMatthew R. Brier, Beau M. Ances, Brian A. Gordon et al.|Science Translational Medicine|2016Cited by 747
Enabling Technologies for Personalized and Precision MedicineDean Ho, Ali Zarrinpar, Stephen R. Quake et al.|Trends in biotechnology|2020Cited by 483
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s diseaseStephen Salloway, Paul Aisen, Tammie L.S. Benzinger et al.|Nature Medicine|2021Cited by 365
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Robert A. Koeppe, Guoqiao Wang et al.|Neurology|2018Cited by 322
The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression modelRandall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger et al.|Alzheimer s & Dementia|2016Cited by 303